FindTrial
Sign In

Treatment of Heart Disease

An open labelled RCT study to assess the combined effect of nitya anulomana, bilwadi taila hridbasti, tapyadi vataka and chatushparni rasayana in ischemic heart disease (vata kaphaja hridroga). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073740
Enrollment
40
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I259- Chronic ischemic heart disease, unspecified

Interventions

None listed

Sponsors

Pandit Taranath Government Ayurveda Medical college & hospital ballary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of stable IHD Patients with signs and symptoms of vata kaphaja hridaroga Patients with dislipedemia and hyperlipidemia Patients with 2D ECHO diagnosed IHD patients with ejection fraction above 25 percent

Exclusion criteria

Exclusion criteria: Who does not provied written consent CCF Acute MI Preganant and lactating women

Design outcomes

Primary

MeasureTime frame
correction in ejection fraction relief in Hrutashoola, Arohana ayasa Bhrama Hridasthambha Palpitation Padashopha etc.Timepoint: 9 weeks 0 days—

Secondary

MeasureTime frame
prevantion from complications Timepoint: 9 weeks 0 days—

Countries

India

Contacts

Public ContactDr Shraddha Joge

Taranath Government Ayurveda Medical College and Hospital

mvdbly@gmail.com9844094290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026